Startups.Bio showcases an emerging biotech startup each week, selected by the analyst team at VentureRadar from the 10,000s of companies we track.
Latest featured startups
Founded in 2023, Cytospire Therapeutics is developing a portfolio of next-generation immune cell engagers for treating cancer. The company’s multispecific antibodies are designed to harness and direct the power of both innate and adaptive immune systems, providing a safer and more precise alternative to conventional CD3-based therapies. This is made possible by targeting a unique […]
The biotech sector continues to see a strong flow of new venture capital deals, with a flurry of new announcements this week. We saw a diverse set of companies—ranging from AI-driven drug discovery startups to firms advancing radiotherapeutic and oligonucleotide technologies—garner significant investments. Here’s a roundup of the key deals that showcase the current innovation […]
THRONCAT is a new startup that aims to transform the field of protein analysis and mRNA therapeutics safety. THRONCAT began with a mission to make protein analysis more accessible and sensitive. Current techniques for measuring changes in protein synthesis and degradation often fall short in sensitivity and simplicity, limiting scientists’ ability to fully understand disease […]